Schedule iii

By

28-05-2026

DOJ Rescheduling Move Reshapes Medical Cannabis Policy and Business Outlook

The federal government's decision to move state-licensed medical cannabis and FDA-approved marijuana products from Schedule I to Schedule III under the Controlled Substances Act marks the most

• DOJ rescheduling

By

25-05-2026

Federal Marijuana Rescheduling Reshapes Compliance and Tax Math for Cannabis Operators

The Department of Justice moved in April to reclassify certain marijuana products from Schedule I to Schedule III under the Controlled Substances Act - the most significant shift in federal drug

• Federal Marijuana Rescheduling

By

03-05-2026

DEA Moves Medical Cannabis Off Schedule I, Reshaping Federal Drug Policy

For the first time in more than fifty years, the federal government is prepared to treat cannabis as something other than a substance with no accepted medical use. In April, the Department of Justice

• DEA